Summit Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Summit Wealth Partners's AMGN Position: Q2 2026 in Review
Summit Wealth Partners held its Amgen (AMGN) position steady in Q2 2026 at 1,372 shares worth $497K. The position accounts for 0.07% of the portfolio, ranked #175.
Summit Wealth Partners first reported a position in AMGN in Q2 2020 and has held it in 22 quarters since. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Summit Wealth Partners held 1,372 shares of Amgen worth $497K as of Q2 2026.
- Summit Wealth Partners left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.07% of Summit Wealth Partners's portfolio in Q2 2026, its #175 holding.
- Summit Wealth Partners first reported a position in Amgen in Q2 2020 and has held it in 22 quarters since.
- 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Summit Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.